Main
>
INFLUENZA VIRUS
>
Infection. Vaccines. Additives
>
Recombinant NeurAminidase
>
Co.: USA. P (Dev./Patents)
>
Market. Expected by 2007
Market. Expected by 2007's products
This section has no products